Advertisement Neuisys wins FDA clearance for new computed tomography system - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Neuisys wins FDA clearance for new computed tomography system

Neuisys Imaging System Solutions has announced that the FDA has granted 510(k) clearance for its NeuViz 16 multi-slice computed tomography system.

The NeuViz 16 is developed by Philips Neusoft Medical Systems, a joint venture between Royal Philips Electronics of the Netherlands and Neusoft of China.

Kim Russell, president and CEO of Neuisys, said: “The NeuViz 16 is a state-of-the-art computed tomography (CT) system that provides superior performance for the price and provides the clinical benefits of routine, sub-millimeter resolution, volume imaging and low-dose protocols.

“The NeuViz 16 packs a tremendous amount of technology into a very economical footprint and is the perfect solution for diagnostic imaging centers and community hospitals that plan to upgrade from older single or multi-slice CT systems to 16-slice CT as well as a wide array of specialist physician groups considering in-office CT including urologists, gastroenterologists, pulmonologists, surgeons and oncologists.”